Iterum develops and implements its strategies with customers' unique needs in mind, securing its position as a trusted partner and market leader.
SAN ANTONIO, Feb. 22, 2023 /PRNewswire/ -- Frost & Sullivan Frost & Sullivan continues…
DUBLIN, Ireland and CHICAGO, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (“Iterum Therapeutics”), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat…